Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

P&U's Genotropin approved by FDA for adult growth hormone deficiency

Nov. 12, 1997

FDA clears new indication for Zocor

Nov. 11, 1997

Orphan Medical receives approvable letter from FDA for Sucraid

Nov. 11, 1997

PPAR-gamma agonists for endocrine and metabolic disorders

Nov. 11, 1997

Novartis reports protein tyrosine kinase inhibitors for bone disorders

Nov. 10, 1997

Cerebrus uses studies on Redux to design new antiobesity agents

Nov. 10, 1997

Profile of Green Cross's rHSA

Nov. 7, 1997

Cell Genesys reports delivery of erythropoietin gene therapy

Nov. 7, 1997

Neuropeptide Y5 receptor emerges as an important new target in obesity

Nov. 6, 1997

NPS and SmithKline Beecham extend osteoporosis agreement

Nov. 5, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...